Back

Upstream Bio presents Phase 2 verekitug results at ERS Congress 2026

Verifying
  • Upstream Bio presented VALIANT trial results for verekitug in severe asthma.
  • The study was a Phase 2 trial of verekitug.
  • The results were delivered in an oral presentation at ERS Congress 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.